Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Change in Account Payables (2016 - 2020)

Historic Change in Account Payables for Forte Biosciences (FBRX) over the last 5 years, with Q4 2020 value amounting to $25000.0.

  • Forte Biosciences' Change in Account Payables fell 9663.98% to $25000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$369000.0, marking a year-over-year decrease of 13780.74%. This contributed to the annual value of $3.0 million for FY2024, which is 101476.01% up from last year.
  • As of Q4 2020, Forte Biosciences' Change in Account Payables stood at $25000.0, which was down 9663.98% from -$1.4 million recorded in Q3 2020.
  • In the past 5 years, Forte Biosciences' Change in Account Payables ranged from a high of $3.1 million in Q3 2018 and a low of -$1.4 million during Q3 2020
  • Moreover, its 5-year median value for Change in Account Payables was $50500.0 (2016), whereas its average is $137850.0.
  • Its Change in Account Payables has fluctuated over the past 5 years, first surged by 887352.94% in 2018, then plummeted by 135277.78% in 2020.
  • Quarter analysis of 5 years shows Forte Biosciences' Change in Account Payables stood at -$278000.0 in 2016, then surged by 389.21% to $804000.0 in 2017, then crashed by 237.69% to -$1.1 million in 2018, then surged by 167.21% to $744000.0 in 2019, then tumbled by 96.64% to $25000.0 in 2020.
  • Its Change in Account Payables was $25000.0 in Q4 2020, compared to -$1.4 million in Q3 2020 and $1.9 million in Q2 2020.